SCHEMBL5196336

SCHEMBL5196336

C[C@H]1[C@H](C(=O)O)N1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP2C19 P33261 2/20 0.36
KCNN4 O15554 1/20 0.36
HIF1A Q16665 1/20 0.36
CYP1A2 P05177 2/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
SSTR4 P31391 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16498030 1.00 MAPT (0.37) MAPTKMT2ACYP2C19KCNN4HIF1A
SCHEMBL5195703 1.00 MAPT (0.37) MAPTKMT2ACYP2C19KCNN4HIF1A
SCHEMBL15668593 0.83 KCNN4 (0.43) KMT2AKCNN4CYP1A2HDAC3HDAC4
SCHEMBL6036537 0.83 KCNN4 (0.43) KMT2AKCNN4CYP1A2HDAC3HDAC4
SCHEMBL833033 0.83 KCNN4 (0.43) KMT2AKCNN4CYP1A2HDAC3HDAC4
SCHEMBL15668595 0.83 KCNN4 (0.43) KMT2AKCNN4CYP1A2HDAC3HDAC4
SCHEMBL30775651 0.83 SSTR4 (0.36) MAPTKMT2ACYP2C19KCNN4HIF1A
SCHEMBL5427678 0.83 KCNN4 (0.43) KMT2AKCNN4CYP1A2HDAC3HDAC4
SCHEMBL18649120 0.83 KCNN4 (0.43) KMT2AKCNN4CYP1A2HDAC3HDAC4
SCHEMBL23297726 0.77 CYP1A2 (0.39) MAPTKMT2ACYP2C19KCNN4HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812383-A1 GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF Smithkline Beecham Corporation (US) 2007-08-01 EP disclosed
WO-2006052722-A1 GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF SMITHKLINE BEECHAM CORPORATION (US) 2006-05-18 WO disclosed